You can only gain access to certain items and special pricing if you have logged in. Login Now.
Bringing a Stand-Alone Immune Effector Cellular Therapy Program into FACT Compliance
Format:
Electronic (digital download/no shipping)
Accredited Organization, Guest, NonMember -
$100.00
Industry -
$500.00
Inspector, Inspector Trainee -
$0.00
Description:
This presentation was live on Wednesday, August 26, 2020. Presenters explained the rationale for FACT accreditation of immune effector cell programs, and compared and contrasted immune effector cell therapy with other non-cell-based therapies. Presenters also summarized the major concepts addressed in the FACT IEC Standards and how to plan a self-assessment against the FACT IEC Standards. Presenters include: Elizabeth Shpall, MD Cord Blood Bank Medical Director, Cellular Therapy Processing Facility Director and Medical Director The University of Texas MD Anderson Cancer Center Stem Cell Transplantation and Cellular Therapy Kris Michael Mahadeo MD, MPH Associate Professor/Section Chief Pediatric SCT-CT The University of Texas MD Anderson Cancer Center Stem Cell Transplantation and Cellular Therapy Alison Gulbis, PharmD The University of Texas MD Anderson Cancer Center Stem Cell Transplantation and Cellular Therapy
Product Details:
| Product ID: | 12346 |
|---|---|
| Publication Year: | 2020 |
| Pages, Size, or Length: | 72 minutes |
